03.08.2022 17:40:00
|
Neurones: Organic growth up 12.5% in 1st half 2022
PRESS INFORMATION Nanterre, August 3, 2022 (after trading)
Section: 1st half 2022 revenues
Organic growth up 12.5% in 1st half 2022
Revenues (millions of euros) | 2021 | 2022 | Growth | of which organic |
Q1 | 144.2 | 162.6 | + 12.8% | + 12.2% |
Q2 | 145.1 | 164.5 | + 13.4% | + 12.8% |
Total H1 revenues | 289.3 | 327.1 | + 13.1% | + 12.5% |
Achievements
With 12.8% organic growth in the second quarter (vs. 12.2% in the first quarter), NEURONES has maintained its sustained growth for several quarters.
There are still many opportunities related to digital transformation. The strong demand in Digital, Cloud, Cybersecurity, as well as in SAP Consulting and Integration, makes for a certain selectivity.
Despite persistent recruitment tensions, increasing recourse to subcontracting and high turnover, operating profit for the half-year (¹) rose by 22.1% to reach 11.3% of revenue (compared with 10.5% in H1 2021).
(¹) unaudited and after 0.4% of expenses related to bonus shares.
Outlook
In an uncertain global environment, for the moment there are no signs of a slowdown in demand for digital services. In this context, NEURONES is raising its forecasts and now anticipates the following for the whole year:
- revenues of at least €640m (vs. €625m previously forecast),
- an operating profit of around 10.5% (vs > 10%).
About NEURONES
With over 6,000 experts, and ranking among the French leaders in management consulting and digital services, NEURONES helps large companies and organizations implement their digital projects, transform their IT infrastructures and adopt new uses.
Euronext Paris (compartment B - NRO) - Euronext Tech Leaders -DSS mid caps
www.neurones.net
Press Relations: O'Connection Valérie Hackenheimer Tel.: +33 (0)6 12 80 35 20 vhackenheimer@oconnection.fr | NEURONES Matthieu Vautier Tel.: +33 (0)1 41 37 41 37 rp@neurones.net | Investor Relations: NEURONES Paul-César Bonnel Tel.: +33 (0)1 41 37 41 37 investisseurs@neurones.net |
Attachment
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu NeuronesAct.mehr Nachrichten
Keine Nachrichten verfügbar. |